Ocular Drugs Flashcards
Peri-ocular injections
less common, reach behind iris-lens diaphragm, bypasses conjunctiva and corneal epithelium which is good for drugs with low lipid solubility
Intraocular injection types
intracameral or intravitreal, intravitreal anti-VEGF- macular degeneration, intrav steroid- macular edema, intrav antibiotics- endophthalmitis, intraocular acetylcholine- cataract surgery
Ophthalmic medication
Cholinergic agonists, sympathomimetics, BBs, carbonic anhydrous inhibitors, prostaglandin analogues, intraocular decongestants, anticholinergic agents, NSAIDs, corticosteroids, antihistamines, antiinfectives
Glaucoma
intraocular pressure> 30 mmHg, open is chronic and closed is severe and acute, goal is to prevent vision loss, multiple agents give at least 10 mins apart
Cholinergic agonists
pilocarpine, carbachol
Cholinergic agonist MOA
cause miosis by contraction of the iris sphincter muscle which increases aqueous humor flow through the trabecular meshwork by longitudinal cilliary muscle contraction, accommodation
Cholinergic clinical uses
miosis, glaucoma, usually second or third line
Cholinergic ADRs
HA from accomadative spasm, retinal detachment (rare), systemic cholinergic effects are rare
Anticholinergic agents
atropine, cyclopentolate, phenylephrine (Cyclomydril), Tropicamide (Midriacyl)
Anticholinergic agents MOA
causes mydriasis by paralyzing the sphincter muscle and also causes cycloplegia by paralyzing the cilliary muscle
Anticholinergic clinical uses
eye exams where dilation is needed to facilitate exam of retina, fundoscopy, cycloplegic refraction, sublingual use of atropine drops for terminal secretions
Anticholinergic agents ADRs
blurred vision, nausea, vomiting, pallor, constipation, urinary retention
Sympathomimetics
epinephrine, brimonidine (Alphagan), TID drug
Sympathomimetics MOA
a2 agonist that reduces IOP by reducing the production of aqueous humor and improving drainage
Sympathomimetics Clinical use
open angle glaucoma, ocular HTN, can be used to prevent IOP post op
Sympathomimetcs ADRs
fatigue, conjunctival blanching, mydriasis, VERY well tolerated
Beta blockers
Timolol (Timoptic), Levobunolol (Betagan), Betaxolol (Betoptic)
Beta blockers MOA
reduce intraocular pressure by blocking B2 in ciliary epithelium, reduces production of aqueous humor, given BID except Timoptic
Beta blockers use
glaucoma
Beta blocker ADR
stinging, rarely systemic
Carbonic anhydrous inhibitors
Acetazolamide (diamox) (rare), Dorzolamide (Trusopt) (TID, Brinzolamide (Azopt) (TID)
Carbonic anhydrous inhibitors MOA
reduce IOP by buffering an acid residue which may be present in secretory cells as a result of production of aqueous humor
Carbonic anhydrous inhibitors Use
ocular HTN, glaucoma
Carbonic anhydrous inhibitors ADR
stinging, burning, bitter taste, Dorzolamide known for systemic absorption
Prostaglandin analogues
Bimatoprost (Lumigan), Latanoprost (Xalatan) generic available, Travoprost (Travatan)
Prostaglandin analogues MOA
reduce IOP by increasing aqueous humor drainage via a process not previously targeted
Prostaglandin analogues use
ocular HTN and glaucoma
Prostaglandin analogues ADRs
local irritation, iris pigmentation
Prostaglandin Pearls
first line, most efficacious, once daily dosing, combo available
Suspected pathogens of eye infections
str, pneumoniae, staph aureus, hemophilus sp, proteus sp, Klebsiella sp
Anti infective ophthalmic agents
Bacitracin, neomycin, sulfa (first line, cheap); erythromycin (all infants), tobramycin, Gentamicin (gram - bac), Cipro (gram -, cheap), levofloxacin (broad spectrum, $$), Moxifloxacin (recurrent infections, $$)
Anti infective ophthamic agents Pearls
similar to other infections, cultures not always obtained, response in few days, change to broad spectrum if no improvement
Intraocular decongestants
tetrahydrozoline (visine), oxymeazoline (Visine LR)
Intraocular decongestants MOA
sympathomimetic activity, promote constriction to result in clearing red eyes
Intraocular decongestant Pearls
red eyes, no ADR, risk of dependency (no more than 72 hrs)
Artificial tears
Many products available, balance salt solutions with viscosity inducing agents to prolong contact time, for dry eyes, may temporarily blur vision, very cheap
Intraocular NSAIDs
Diclofenac (Voltaren), Ketorolac (Acular), $$$
Intraocular NSAIDs MOA
inhibit COX I and II resulting in production of inflammatory mediaters
Intraocular NSAID uses
intraoperative miosis, inflammation post op, seasonal conjuctivitis, macular edema
Ocular antihistamines
Olopatadine (Patanol), Ketotifen (Zaditor), Azelastine (Optivar)
Ocular antihistamines MOA and use and ADR
histamine receptor blockers and mast cell stabilizers; for allergic conjuctivitis, mostly for prevention, burning, stinging
Ocular antihistamine Pearls
$$$, limit use to pt with ocular sx not controlled with systemic therapy or GLAUCOMA pts
Corticosteroids
Fluorometholone, prednisolone, dexamethoasone, hydrocortisone
Corticosteroids MOA
inhibition of arachadonic acid release from phospholipids by inhibiting prospholipase A2
Corticosteroids clinical use
postop, anterior uveitis, sever allergic conjuctivitis, vernal keratoconjunctivitis, prevention and suppression of corneal graft rejection, episcleritis, scleritis
Corticosteroids ADR
increased susceptibility to infections, glaucoma, cataract, mydriasis, scleral melting
Ocular complications associated with systemic drugs
ibuprofen, lovastatin, CCB, allopurinol (form cataract), amiodarone